Current Status and the Need for CFTR Modulator Therapy in Cystic Fibrosis Patients in Mainland China: A Case Report and Literature Review
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Yuxiao Sun, Junbao Du, Lifen Gong, Jialiang Wang, Jing Zhang, Yaqin Xu, Lei Wang, Ziwei Zhang, Hang Cheng |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
por: Rebecca Gallardo, et al.
Publicado: (2026)
por: Rebecca Gallardo, et al.
Publicado: (2026)
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
por: Tyler Shugg, et al.
Publicado: (2025)
por: Tyler Shugg, et al.
Publicado: (2025)
Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
por: Jeremy P. Tervo, et al.
Publicado: (2025)
por: Jeremy P. Tervo, et al.
Publicado: (2025)
Disparities in Access to Cystic Fibrosis Therapy Across Countries
por: Bulent Karadag
Publicado: (2026)
por: Bulent Karadag
Publicado: (2026)
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
por: Gabriela R. Oates, et al.
Publicado: (2025)
por: Gabriela R. Oates, et al.
Publicado: (2025)
Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy
por: Julianna Bailey, et al.
Publicado: (2026)
por: Julianna Bailey, et al.
Publicado: (2026)
E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
por: Maryam Sahibqran, et al.
Publicado: (2024)
por: Maryam Sahibqran, et al.
Publicado: (2024)
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
por: Emma M. Tillman, et al.
Publicado: (2025)
por: Emma M. Tillman, et al.
Publicado: (2025)
Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor‐Tezacaftor‐Ivacaftor Therapy
por: Kimberly Pasley, et al.
Publicado: (2024)
por: Kimberly Pasley, et al.
Publicado: (2024)
Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
por: Suzanne Kroes, et al.
Publicado: (2026)
por: Suzanne Kroes, et al.
Publicado: (2026)
Expanding the Impact of New Cystic Fibrosis Therapies in Low‐ and Middle‐Income Countries
por: Eitan Kerem
Publicado: (2024)
por: Eitan Kerem
Publicado: (2024)
Feeding the Need: A Study on Food Security Among People With Cystic Fibrosis in Turkey
por: Damla Kocaman, et al.
Publicado: (2025)
por: Damla Kocaman, et al.
Publicado: (2025)
Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function?
por: C. M. López Cárdenes, et al.
Publicado: (2026)
por: C. M. López Cárdenes, et al.
Publicado: (2026)
Knowledge, Attitudes, and Behaviors of Cystic Fibrosis Patients on Reproductive Health in Turkiye
por: Hande Yuce Ozdemir, et al.
Publicado: (2025)
por: Hande Yuce Ozdemir, et al.
Publicado: (2025)
Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey
por: Birce Sunman, et al.
Publicado: (2025)
por: Birce Sunman, et al.
Publicado: (2025)
Pathophysiology of Cystic Fibrosis Liver Disease
por: Vania L. Kasper, et al.
Publicado: (2024)
por: Vania L. Kasper, et al.
Publicado: (2024)
Roadmap to Global Cystic Fibrosis Care
por: Samya Z. Nasr, et al.
Publicado: (2025)
por: Samya Z. Nasr, et al.
Publicado: (2025)
Cystic Fibrosis Year in Review 2024
por: Adrienne P. Savant
Publicado: (2025)
por: Adrienne P. Savant
Publicado: (2025)
Baseline Characteristics and Self‐Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO‐2) Cohort
por: Georgene E. Hergenroeder, et al.
Publicado: (2025)
por: Georgene E. Hergenroeder, et al.
Publicado: (2025)
Persistence of Viable But Non‐Culturable Stenotrophomonas maltophilia in a Cystic Fibrosis Patient
por: Gianmarco Mangiaterra, et al.
Publicado: (2025)
por: Gianmarco Mangiaterra, et al.
Publicado: (2025)
Expanding Cystic Fibrosis Registries to the Rest of the World
por: Lutz Naehrlich
Publicado: (2026)
por: Lutz Naehrlich
Publicado: (2026)
“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
por: Tuğba Şişmanlar Eyüboğlu, et al.
Publicado: (2026)
por: Tuğba Şişmanlar Eyüboğlu, et al.
Publicado: (2026)
Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
por: Chelsea Flora, et al.
Publicado: (2026)
por: Chelsea Flora, et al.
Publicado: (2026)
Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
por: Laurie P. Murray, et al.
Publicado: (2025)
por: Laurie P. Murray, et al.
Publicado: (2025)
The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
por: Rebecca J. Vitale, et al.
Publicado: (2026)
por: Rebecca J. Vitale, et al.
Publicado: (2026)
Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
por: Sean Coyne, et al.
Publicado: (2024)
por: Sean Coyne, et al.
Publicado: (2024)
Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
por: Brittany A. Wright, et al.
Publicado: (2025)
por: Brittany A. Wright, et al.
Publicado: (2025)
Global Research Status and Trends in Quality of Life in Children With Cystic Fibrosis From 1985 to 2025: A 40‐Year Bibliometric Analysis
por: Kızbes Meral Kılıç, et al.
Publicado: (2026)
por: Kızbes Meral Kılıç, et al.
Publicado: (2026)
CFTR Modulators in Brazil: Not for Everyone—A Comparison of Ineligibility Across Different Regions
por: Edna Lúcia D' Souza, et al.
Publicado: (2026)
por: Edna Lúcia D' Souza, et al.
Publicado: (2026)
Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
por: Elizabeth Clarke, et al.
Publicado: (2024)
por: Elizabeth Clarke, et al.
Publicado: (2024)
Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
por: Lauren N. Kormelink, et al.
Publicado: (2024)
por: Lauren N. Kormelink, et al.
Publicado: (2024)
Pica‐Induced Airway Obstruction in Paediatric Cystic Fibrosis: An Unexpected Culprit
por: Anna Šmejkalová, et al.
Publicado: (2025)
por: Anna Šmejkalová, et al.
Publicado: (2025)
A Dose of Hope: Successful Tobramycin Desensitization in Pediatric Cystic Fibrosis
por: Isabel G. Wedig, et al.
Publicado: (2025)
por: Isabel G. Wedig, et al.
Publicado: (2025)
Sleep‐Disordered Breathing in Cystic Fibrosis in Low‐ and Middle‐Income Countries
por: Merve Selçuk Balcı, et al.
Publicado: (2026)
por: Merve Selçuk Balcı, et al.
Publicado: (2026)
Infant Lung Function in Cystic Fibrosis: A Real‐World Study
por: Michele Arigliani, et al.
Publicado: (2025)
por: Michele Arigliani, et al.
Publicado: (2025)
Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality
por: Marco Zampoli, et al.
Publicado: (2025)
por: Marco Zampoli, et al.
Publicado: (2025)
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
por: Leslie Huang, et al.
Publicado: (2025)
por: Leslie Huang, et al.
Publicado: (2025)
Anxiety in the Pediatric Cystic Fibrosis Population: Evaluation of a Younger Cohort
por: Jemilla Strode Smith, et al.
Publicado: (2025)
por: Jemilla Strode Smith, et al.
Publicado: (2025)
Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms
por: Kellyn Madden, et al.
Publicado: (2024)
por: Kellyn Madden, et al.
Publicado: (2024)
Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
por: Andrea L. Fidler, et al.
Publicado: (2025)
por: Andrea L. Fidler, et al.
Publicado: (2025)
Ejemplares similares
-
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
por: Rebecca Gallardo, et al.
Publicado: (2026) -
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
por: Tyler Shugg, et al.
Publicado: (2025) -
Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
por: Jeremy P. Tervo, et al.
Publicado: (2025) -
Disparities in Access to Cystic Fibrosis Therapy Across Countries
por: Bulent Karadag
Publicado: (2026) -
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
por: Gabriela R. Oates, et al.
Publicado: (2025)